These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 30157114

  • 1. LONG-TERM VISUAL OUTCOMES AND CLINICAL FEATURES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION-RELATED ENDOPHTHALMITIS.
    Rayess N, Obeid A, Storey PP, Juliano J, Rahimy E, Moshfeghi AA, Garg S, Hsu J.
    Retina; 2019 Nov; 39(11):2070-2076. PubMed ID: 30157114
    [Abstract] [Full Text] [Related]

  • 2. Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Management and Visual Outcomes.
    Xu K, Chin EK, Bennett SR, Williams DF, Ryan EH, Dev S, Mittra RA, Quiram PA, Davies JB, Parke DW, Johnson JB, Cantrill HL, Almeida DRP.
    Ophthalmology; 2018 Aug; 125(8):1279-1286. PubMed ID: 29477689
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab.
    Storey PP, Tauqeer Z, Yonekawa Y, Todorich B, Wolfe JD, Shah SP, Shah AR, Koto T, Abbey AM, Morizane Y, Sharma P, Wood EH, Morizane-Hosokawa M, Pendri P, Pancholy M, Harkey S, Jeng-Miller KW, Obeid A, Borkar DS, Chen E, Williams P, Okada AA, Inoue M, Shiraga F, Hirakata A, Shah CP, Prenner J, Garg S, Post-Injection Endophthalmitis (PIE) Study Group.
    Am J Ophthalmol; 2019 Mar; 199():200-208. PubMed ID: 30552891
    [Abstract] [Full Text] [Related]

  • 6. Management and Visual Outcomes of Acute Bacterial Endophthalmitis Following Intravitreal Injection of Contaminated Bevacizumab in a Single Day.
    Xu K, Mousa R, Loewenstein A, Barak A, Chin EK, Almeida DRP.
    Ophthalmic Surg Lasers Imaging Retina; 2020 Jun 01; 51(6):346-352. PubMed ID: 32579693
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration.
    Daien V, Nguyen V, Essex RW, Morlet N, Barthelmes D, Gillies MC, Fight Retinal Blindness! Study Group.
    Ophthalmology; 2018 Jan 01; 125(1):66-74. PubMed ID: 28801117
    [Abstract] [Full Text] [Related]

  • 16. Lid splinting eyelid retraction technique: a minimised sterile approach for intravitreal injections.
    Munro M, Williams GR, Ells A, Fielden M, Kherani A, Mitchell P, Ruzicki J, Adatia FA.
    Br J Ophthalmol; 2018 Sep 01; 102(9):1254-1258. PubMed ID: 29246893
    [Abstract] [Full Text] [Related]

  • 17. Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and Aflibercept.
    Rayess N, Rahimy E, Storey P, Shah CP, Wolfe JD, Chen E, DeCroos FC, Garg SJ, Hsu J.
    Am J Ophthalmol; 2016 May 01; 165():88-93. PubMed ID: 26944277
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor.
    Kim KH, Kim JH, Chang YS, Lee TG, Kim JW, Lew YJ.
    Korean J Ophthalmol; 2015 Oct 01; 29(5):315-24. PubMed ID: 26457037
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.